In the general news, bogus terrorist bomb threats closed all schools in Los Angeles. Donald Trump stayed in the public spotlight, and the Fed finally raised interest rates by 0.25%.
In healthcare business news, Turing Pharma’s scandalous attention-loving CEO, Martin Shkreli, was arrested for allegedly running a Ponzi scheme using his various hedge funds and companies. Valeant (VRX) stock spiked 20% after analyst day. They also signed a new drug distribution deal with Walgreens (WBA). Lastly, large hospital mergers are getting pushback from the FTC.
From the FDA, Lilly’s (LLY) diabetes drug Basaglar was approved as a cheaper alternative to Sanofi-Aventis’ Lantus. Lastly, the agency will move to ban tanning beds for people under the age of 18.